Mar. 24, 2023

PF-07258669

oral melanocortin-4 receptor antagonist Ph. I candidate focused screen of 28K library for MC4R activity J. Med. Chem., February 19, 2023 Pfizer Inc., Groton, CT

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in